Trial Profile
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2023
Price :
$35
*
At a glance
- Drugs Avelumab (Primary) ; Cisplatin; Fluorouracil; Mitomycin
- Indications Bladder cancer; Carcinoma
- Focus Therapeutic Use
- 12 Mar 2021 Status changed from active, no longer recruiting to completed.
- 28 May 2019 Planned primary completion date changed from 31 Jul 2025 to 13 Nov 2019.
- 14 May 2019 Status changed from recruiting to active, no longer recruiting.